Recent evidence from the STEP-HFpEF and STEP-HFpEF-DM trials provides the first robust data supporting the efficacy of GLP-1 RAs, specifically semaglutide, in improving the quality of life in obese patients with HFpEF
Medical disclaimer: Lab testing supports informed decisions but does not diagnose every medication complication or replace professional medical care
You can use the abdomen, thigh, or upper arm, whether your medication comes in a prefilled pen or a vial and syringe
When Futurism contacted doctors listed on MEDVis site, at least one, osteopathic practitioner Tzvi Doron, said he had no association with the company and requested removal
Originally designed for blood glucose control and weight management, these drugs have shown broader benefits: Improving insulin sensitivity Reducing systemic inflammation Enhancing microvascular blood flow Supporting metabolic repair in tissues possibly including nerves Thats why researchers have started asking whether GLP-1 agonists could protect or even repair diabetic nerves